{
  "Income Statement": {
    "Revenue": "28,262.9",
    "Cost of Sales": "13,770.9",
    "Gross Profit": "14,492.0",
    "Research and Development Expenses": "4,303.7",
    "Selling, General and Administrative Expenses": "1,165.7",
    "Operating Income": "9,022.6",
    "Interest and Other Income, Net": "19.8",
    "Income Before Taxes": "9,042.4",
    "Income Tax Expense": "(1,680.6)",
    "Net Income": "7,571.6",
    "Earnings from Equity Method Investments": "209.8",
    "Basic Earnings per Share": "19.25",
    "Diluted Earnings per Share": "19.24",
    "Personnel Expenses": "6,037.4",
    "Share-Based Compensation": "172.6"
  },
  "Balance Sheet": {
    "Total Assets": "48,589.6",
    "Cash and Cash Equivalents": "12,735.9",
    "Short-Term Investments": "5.4",
    "Accounts Receivable, Net": "4,477.5",
    "Inventories, Net": "10,891.5",
    "Total Current Assets": "30,737.4",
    "Property, Plant and Equipment, Net": "6,846.8",
    "Goodwill": "4,588.6",
    "Total Non-Current Assets": "17,852.2",
    "Total Liabilities": "30,112.8",
    "Accounts Payable": "3,500.4",
    "Current Portion of Long-Term Debt": "1,010.3",
    "Total Shareholders' Equity": "18,476.8",
    "Retained Earnings": "14,414.3",
    "Total Liabilities and Shareholders' Equity": "48,589.6"
  },
  "Cash Flow Statement": {
    "Net Cash Provided by Operating Activities": "11,166.2",
    "Net Cash Used in Investing Activities": "(2,609.3)",
    "Net Cash Used in Financing Activities": "(2,832.1)",
    "Effect of Exchange Rate Changes on Cash": "6.4",
    "Net Increase in Cash and Cash Equivalents": "5,731.2",
    "Cash and Cash Equivalents at End of Period": "12,735.9",
    "Purchases of Property, Plant and Equipment": "(2,083.1)",
    "Free Cash Flow": "9,083.1",
    "Depreciation and Amortization": "918.6",
    "Share-Based Compensation Expense": "172.6",
    "Accounts Receivable, Net": "-139.9",
    "Inventories": "-1,860.9",
    "Accounts Payable": "1,127.6"
  }
}